CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the Rodman & Renshaw Annual Global Investment Conference on Monday, September 10, 2012 at 10:50 a.m. ET at the Waldorf=Astoria hotel in New York City.
